Clinical TrialsSearch results
Number of results: 823
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB054707 When Administered Orally to Healthy Japanese Participants
- Inflammatory disease
- On Shintaro
- 2021-10-18
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Axatilimab When Administered by Intravenous Infusion to Healthy Japanese Participants
- GVHD, healthy voluteer
- Ono Shintaro
- 2023-02-27
Completed
- A phase 1 open-label study evaluating the effects of food on TAS-205 in healthy volunteers
- Duchenne Muscular Dystrophy
- Takeda Shin'ichi
- 2023-06-25
Completed
- A Phase 1 Mass Balance Study of Oral [14C] TAS-115 in Healthy Adult Male Subjects
- Chronic fibrosing interstitial lung diseases with a progressive phenotype
- Huang Jinhong
- 2021-09-07
Completed
- A pharmacokinetic study of NPC-15 Tablet (for adult use)
- Sleep-onset difficulty associated with mild cognitive impairment or dementia
- Eto Takashi
- 2023-03-02
Completed
- A Ph2, randomized, double-blind, dose finding study to describe the immunogenicity, safety and tolerability of VN-0200 in Japanese adults aged 60-80 years
- Prevention of respiratory syncytial viral infection
- Inoguchi Akihiro
- 2022-09-08
Completed
- A mass-balance study of [14C]KDT-3594 in healthy adult male
- Healthy condition
- Shimizu Yoshitaka
- 2022-10-16
Completed
- A Food Effect Study of TS-142 in Healthy Subjects
- Insomnia
- Mita Seiji
- 2023-02-01
Completed
- A Drug-Drug Interaction Study of TAS5315 with CYP3A inhibitor in Healthy Adult Subjects
- healthy adult males and females
- Nasermoaddeli Ali
- 2023-03-29
Completed
- A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
- Schizophrenia
- Yabuuchi Kazuki
- 2021-04-05